Parkinson Disease, the Effect of Levodopa, and the ELLDOPA Trial
- 1 May 1999
- journal article
- review article
- Published by American Medical Association (AMA) in Archives of Neurology
- Vol. 56 (5) , 529-535
- https://doi.org/10.1001/archneur.56.5.529
Abstract
Research from JAMA Neurology — Parkinson Disease, the Effect of Levodopa, and the ELLDOPA TrialKeywords
This publication has 15 references indexed in Scilit:
- Tyrosine hydroxylase and Parkinson's diseaseMolecular Neurobiology, 1998
- Nigrostriatal Dopaminergic Neurons Remain Undamaged in Rats Given High Doses of l‐DOPA and Carbidopa ChronicallyJournal of Neurochemistry, 1984
- Should Levodopa Therapy Be Started Early or Late?Canadian Journal of Neurological Sciences, 1984
- Chronic Parkinsonism in Humans Due to a Product of Meperidine-Analog SynthesisScience, 1983
- Long‐term administration of L‐DOPA does not damage dopaminergic neurons in the mouseNeurology, 1981
- Evidence to support early levodopa therapy in Parkinson diseaseNeurology, 1981
- AUTOXIDATION VERSUS COVALENT BINDING OF QUINONES AS MECHANISM OF TOXICITY OF DOPAMINE, 6-HYDROXYDOPAMINE, AND RELATED COMPOUNDS TOWARD C1300-NEUROBLASTOMA CELLS INVITRO1978
- Considerations in the management of parkinsonismNeurology, 1978
- Levodopa, Fertility, and LongevityScience, 1977
- Aromatic Amino Acids and Modification of ParkinsonismNew England Journal of Medicine, 1967